$0.57 0.00 (0.00%) Palatin Technologies Inc - NYSE Amex Equities

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.57
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 0.57
Open: 0.54
Bid: 0.50
Ask: 0.75
  1. No results found.
  1. The New Female Libido Drug: Hot or Hype?

    FoxBusiness | Sep. 9, 2015 | 13:29PM EST
  2. Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction

    Benzinga | Aug. 18, 2015 | 20:51PM EST
  3. Chuck Royce Cuts Second Largest Communications Equipement Holding

    GuruFocus | Jul. 7, 2015 | 21:27PM EST
  4. Investor Chuck Royce Cuts Stake in Adtran

    GuruFocus | Jul. 7, 2015 | 21:27PM EST
  5. Worst Performing Industries For June 16, 2015

    Benzinga | Jun. 16, 2015 | 11:36AM EST
  6. Earnings Scheduled For February 13, 2015

    Benzinga | Feb. 13, 2015 | 05:09AM EST
  7. Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

    Benzinga | Dec. 29, 2014 | 07:31AM EST
  8. Earnings Scheduled For September 9, 2014

    Benzinga | Sep. 9, 2014 | 05:24AM EST
  9. Palatin Technologies Contacted by NYSE Regarding Market Activity

    Benzinga | Jan. 13, 2014 | 16:32PM EST
  10. Earnings Scheduled For September 30, 2013

    Benzinga | Sep. 30, 2013 | 05:32AM EST
  11. Palatin Technologies, Inc. (PTN) CFO Stephen T Wills buys 10,000 Shares

    GuruFocus | Jan. 2, 2013 | 09:06AM EST
  12. Palatin Technologies, Inc. (PTN) CEO Carl Spana buys 10,000 Shares

    GuruFocus | Jan. 2, 2013 | 09:06AM EST
  13. Benzinga's Microcap Movers for Thursday November 8, 2012

    Benzinga | Nov. 8, 2012 | 15:06PM EST
  14. Palatin Technologies Reports Positive Phase 2B Results for Bremelanotide in Female Sexual Dysfunction Trial

    Benzinga | Nov. 8, 2012 | 01:22AM EST
  15. Earnings Scheduled For September 11, 2012

    Benzinga | Sep. 10, 2012 | 18:16PM EST
Trading Center